Risks and Benefits of Long-Term Use of Nicotine Replacement Therapy (NRT) Products; Public Workshop
The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) is announcing a scientific workshop that will focus on the risks and benefits associated with the long-term use of nicotine replacement therapy (NRT) products. NRT products facilitate smoking cessation by ameliorating the symptoms of nicotine withdrawal and are available as approved nonprescription and prescription drugs. No currently approved NRT product is intended for use beyond 12 weeks to relieve the acute withdrawal symptoms experienced when quitting smoking.
Date(s): October 26-27, 2010
Time: 8:30 a.m. to 5:00 p.m.
Location: Radisson Hotel, Reagan National Airport
2020 Jefferson Davis Highway
Arlington, VA 22202
- Federal Register notice (PDF - 54KB)
- Final Workshop Agenda (PDF - 29KB)
- Workshop Speakers and Attendee List (PDF - 32KB)
- Transcript: Tuesday, October 26, 2010 (PDF - 715KB)
- Transcript: Wednesday, October 27, 2010 (PDF - 629KB)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.
- Neal Benowitz, M.D. (PDF - 34KB)
Srikumar Chellappan, Ph.D.(PDF - 57KB) John Cooke, M.D.(PDF - 204KB) Piyali Dasgupta, Ph.D(PDF - 728KB) Phillip Dennis, M.D.(PDF - 191KB) Peter Hajek, Ph.D.(PDF - 17KB) Dorothy Hatsukami, Ph.D.(PDF - 50KB) Steven Hecht, Ph.D.(PDF - 71KB) John Hughes, M.D.(PDF - 915KB) Anne Joseph, M.D., MPH(PDF - 38KB) Thomas Leigh, MBBS(PDF - 57KB) Scott Leischow, Ph.D.(PDF - 17KB) Caryn Lerman, Ph.D.(PDF - 1.1MB) Robert Murray, Ph.D.(PDF - 890KB) Sharon Murphy, Ph.D.(PDF - 69KB) Paul Newhouse, M.D.(PDF - 18KB) Hildegard Schuller, DVM, Ph.D.(PDF - 645KB) Herb Seversen, Ph.D.(PDF - 76KB) Jill Siegfried, Ph.D.(PDF - 28KB) Peter Shields, M.D.(PDF - 33KB)